JP2887681B2 - Manufacturing method of sheet cosmetics - Google Patents
Manufacturing method of sheet cosmeticsInfo
- Publication number
- JP2887681B2 JP2887681B2 JP24795789A JP24795789A JP2887681B2 JP 2887681 B2 JP2887681 B2 JP 2887681B2 JP 24795789 A JP24795789 A JP 24795789A JP 24795789 A JP24795789 A JP 24795789A JP 2887681 B2 JP2887681 B2 JP 2887681B2
- Authority
- JP
- Japan
- Prior art keywords
- magnesium
- hyaluronic acid
- salt
- water
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 45
- 229920002674 hyaluronan Polymers 0.000 claims description 45
- 229960003160 hyaluronic acid Drugs 0.000 claims description 45
- 239000011777 magnesium Substances 0.000 claims description 41
- 229910052749 magnesium Inorganic materials 0.000 claims description 41
- 150000003839 salts Chemical class 0.000 claims description 40
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 claims description 28
- 239000007864 aqueous solution Substances 0.000 claims description 23
- 239000006210 lotion Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 10
- -1 ascorbyl magnesium Chemical compound 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 25
- 210000003491 skin Anatomy 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000002211 L-ascorbic acid Substances 0.000 description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 description 9
- 229960005070 ascorbic acid Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229940010747 sodium hyaluronate Drugs 0.000 description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 238000007710 freezing Methods 0.000 description 7
- 235000000069 L-ascorbic acid Nutrition 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 210000003954 umbilical cord Anatomy 0.000 description 2
- 210000004127 vitreous body Anatomy 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- YJGHGAPHHZGFMF-UHFFFAOYSA-K magnesium;sodium;phosphate Chemical compound [Na+].[Mg+2].[O-]P([O-])([O-])=O YJGHGAPHHZGFMF-UHFFFAOYSA-K 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical group NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、水に対して溶解性の良いシート状の化粧料
の製造法に関するものである。Description: TECHNICAL FIELD The present invention relates to a method for producing a sheet-shaped cosmetic having good solubility in water.
(従来の技術) 従来、瞼、目尻、額、口許、首等の部分に塗布し皮膚
に適度の潤いと「張り」を付与する所謂ワンポイント化
粧料としては、コラーゲン加水分解物をフィルム状に成
型したものか、或いは不織布にコラーゲン加水分解物を
含浸して乾燥したものが使用されてきた。(Prior art) Conventionally, as a so-called one-point cosmetic which is applied to the eyelids, outer corners of the eyes, forehead, mouth, neck and the like to impart appropriate moisture and “tension” to the skin, collagen hydrolyzate is formed into a film. A molded product or a nonwoven fabric impregnated with a collagen hydrolyzate and dried has been used.
ヒアルロン酸またはその塩(以下、ヒアルロン酸
(塩)と略記する)は保湿剤として優れた性質を持って
いるので、皮膚細胞を賦活化し、老化皮膚のターンオー
バーを速め、荒肌改善効果、角質改善効果に著効を呈す
ると共に、皮膚にしっとり感、なめらか感、張り及び艶
を付与し、皮膚を美しくする効果があるとされている。Hyaluronic acid or its salt (hereinafter abbreviated as hyaluronic acid (salt)) has excellent properties as a moisturizer, so it activates skin cells, accelerates the turnover of aging skin, improves rough skin, and improves keratin. It is said to have a remarkable effect on the improvement effect, and to impart a moist feeling, a smooth feeling, a firmness and a luster to the skin, and to make the skin beautiful.
リン酸−L−アスコルビルマグネシウムは、水や空気
に対して安定性が良く経皮吸収されて生体内のホスファ
ターゼ等の酵素によって容易に加水分解されてL−アス
コルビン酸となるもので、肌に対し美白効果があるとさ
れている。Magnesium phosphate, L-ascorbyl phosphate, has good stability to water and air, is absorbed percutaneously, and is easily hydrolyzed to L-ascorbic acid by enzymes such as phosphatase in the living body. It is said to have a whitening effect.
かかる効果を持つヒルロン酸(塩)とリン酸−L−ア
スコルビルマグネシウムの混合体を、瞼、目尻、額、口
許、首等の小皺の出やすい部分に塗布し、皮膚に適度の
潤いと「張り」を付与すると共に、皮膚に対し美白効果
を有するワンポイント化粧料として用いることが望まれ
ていた。A mixture of hiluronic acid (salt) and magnesium-L-ascorbyl phosphate having such an effect is applied to small wrinkle-prone parts such as the eyelids, the outer corner of the eyes, the forehead, the mouth, the neck, and the like, so that the skin has a suitable amount of moisture and a "tension". It has been desired to use the composition as a one-point cosmetic having a whitening effect on the skin.
(発明が解決しようとする課題) しかし、ヒアルロン酸(塩)及びリン酸−L−アスコ
ルビルマグネシウムの乾燥物は粉末であり、ヒアルロン
酸(塩)とリン酸−L−アスコルビルマグネシウムの混
合水溶液を単に乾燥して得られたシート或いはフィルム
は、水或いは化粧水に対して溶解性が非常に悪く、これ
をワンポイント化粧料として用いることが出来なかっ
た。(Problems to be Solved by the Invention) However, the dried product of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate is a powder, and a mixed aqueous solution of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate is simply used as an aqueous solution. The sheet or film obtained by drying had very poor solubility in water or lotion, and could not be used as a one-point cosmetic.
本発明は、皮膚に適度の潤いと「張り」を付与すると
共に、皮膚に対して美白効果を有するワンポイント化粧
料として使用するため上記の如き優れた美容上の効果を
持つヒアルロン酸(塩)とリン酸−L−アスコルビルマ
グネシウムを使用して、水或いは化粧水に対して溶解性
の良いシート状或いはフィルム状化粧料を製造する方法
を提供することを目的とする。The present invention provides hyaluronic acid (salt) having an excellent cosmetic effect as described above for use as a one-point cosmetic having a skin whitening effect while imparting moderate moisture and "tension" to the skin. An object of the present invention is to provide a method for producing a sheet-like or film-like cosmetic having good solubility in water or lotion, using magnesium phosphate-L-ascorbyl phosphate.
(課題を解決するための手段) 本発明は、ヒアルロン酸或いはその塩とリン酸−L−
アスコルビルマグネシウムとを水に溶解した水溶液を薄
層状に真空凍結乾燥することを特徴とする、水、特に化
粧水に易溶解性のシート状化粧料の製造法である。(Means for Solving the Problems) The present invention relates to hyaluronic acid or a salt thereof and phosphoric acid -L-
A method for producing a sheet-like cosmetic which is easily soluble in water, especially a lotion, comprising vacuum-drying an aqueous solution of ascorbyl magnesium and water in a thin layer.
本発明に用いるヒアルロン酸は、関節、硝子体、臍
帯、軟骨、皮膚、鳥類のとさか等の結合組織中にその構
成成分として存在し、組織の柔軟性、構造維持、細胞の
代謝調節等に重要な機能を果たしている。またヒアルロ
ン酸ナトリウムは、高分子物質であり、その溶液は強い
粘弾性を持ち、保水作用を有するところから、化粧品原
料として広く使用できるほか、眼科治療薬、目薬、関節
症治療薬としての用途がある。The hyaluronic acid used in the present invention is present as a constituent component in connective tissues such as joints, vitreous body, umbilical cord, cartilage, skin, and bird crest, and is important for tissue flexibility, structure maintenance, cell metabolism regulation, and the like. Function. In addition, sodium hyaluronate is a high molecular substance, and its solution has strong viscoelasticity and water retention properties, so it can be widely used as a raw material for cosmetics, and it can be used as an ophthalmic treatment, eye drops, and arthrosis treatment. is there.
ヒアルロン酸(塩)は工業的には、にわとりのとさ
か、牛の目の硝子体、又は臍帯等から抽出する抽出法
か、或いはヒアルロン酸を生産する能力を持つ微生物を
培地に培養して製造する方法(醗酵法)が行われてい
る。本発明に用いられるヒアルロン酸(塩)は、抽出法
或いは醗酵法、いずれの方法で製造されたものでもよ
い。Hyaluronic acid (salt) is industrially produced by extracting from chicken crust, vitreous body of cow's eye, umbilical cord, or the like, or by culturing a microorganism capable of producing hyaluronic acid in a culture medium. A method (fermentation method) is being performed. The hyaluronic acid (salt) used in the present invention may be produced by an extraction method or a fermentation method.
現在、工業的に製造されているヒアルロン酸(塩)の
分子量は5万から300万前後のものまであるが、本発明
に用いるヒアルロン酸(塩)の分子量は、この範囲のも
のであれば、いずれのものも用いることが出来る。At present, the molecular weight of hyaluronic acid (salt) industrially produced ranges from about 50,000 to about 3,000,000, but the molecular weight of hyaluronic acid (salt) used in the present invention is within this range. Any of them can be used.
L−アスコルビン酸(ビタミンC)は動植物界に広く
分布し、特に野菜・果物に豊富に含まれる。L−アスコ
ルビン酸は、多様な生理作用・薬理作用を持つことが知
られているが、そのなかでも皮膚の異状色素沈着症への
効果は、古くから化粧品関係者の間で知られていた。皮
膚の色を決定する最大の因子はメラミン色素であるが、
L−アスコルビン酸はメラニンに関し、次の2つの作用
があると云われている。L-Ascorbic acid (vitamin C) is widely distributed in the animal and plant kingdoms, and is particularly abundant in vegetables and fruits. L-ascorbic acid is known to have various physiological and pharmacological actions, and among them, its effect on dyschromatosis of the skin has long been known among cosmetics-related persons. The biggest factor that determines skin color is melamine pigment,
L-ascorbic acid is said to have the following two effects on melanin.
メラニン形成の初期段階で生成されるドーパキノン
をドーパに還元しメラニン形成を抑制する。It reduces dopaquinone produced in the initial stage of melanin formation to dopa and suppresses melanin formation.
メラニンを還元して淡色型にする。 Reduces melanin to a pale form.
ただ、L−アスコルビン酸は乾燥時には比較的安定で
あるが、水溶液中では空気と光により容易に酸化される
欠点を持つので、水溶性で、安定性が高く、化粧品に配
合しやすいL−アスコルビン酸の誘導体が種々研究され
た結果、美白用化粧品原料として下記構造式を持つリン
酸−L−アスコルビルマグネシウムが開発された。本発
明ではこのリン酸−L−アスコルビルマグネシウムを用
いる。However, L-ascorbic acid is relatively stable when dried, but has the drawback that it is easily oxidized by air and light in an aqueous solution. Therefore, L-ascorbic acid is water-soluble, has high stability, and is easily incorporated into cosmetics. As a result of various studies on acid derivatives, magnesium L-ascorbyl phosphate having the following structural formula was developed as a cosmetic whitening ingredient. In the present invention, this magnesium L-ascorbyl phosphate is used.
本発明のヒアルロン酸(塩)とリン酸−L−アスコル
ビルマグネシウムを水に溶解した水溶液を薄層状に真空
凍結乾燥する方法は、次のように行う。先ず、ヒアルロ
ン酸(塩)の0.05〜2.0重量%水溶液を作る。ヒアルロ
ン酸(塩)は水に溶け難く、いわゆるママコになり易い
ので、水を良く撹拌しつつ徐々にヒアルロン酸(塩)を
添加して完全に溶解せしめる。このようにして得られた
ヒアルロン酸(塩)の0.05〜2.0重量%水溶液にリン酸
−L−アスコルビルマグネシウムを加えて良く撹拌して
完全に溶解せしめる。リン酸−L−アスコルビルマグネ
シウムの溶解度は15〜20%であるので、加える量は、リ
ン酸−L−アスコルビルマグネシウムの量として0.05〜
15.0重量%程度になるようにするのが望ましい。この場
合、リン酸−L−アスコルビルマグネシウムの濃厚水溶
液を別途作っておき、これとヒアルロン酸(塩)の水溶
液とを混合してもかまわない。本発明において、ヒアル
ロン酸(塩)とリン酸−L−アスコルビルマグネシウム
の比は任意に変え得るが、実用的にはヒアルロン酸
(塩)1重量部に対しリン酸−L−アスコルビルマグネ
シウムは0.1〜50重量部が望ましい。 The method of vacuum freeze-drying an aqueous solution of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate in water in the form of a thin layer according to the present invention is performed as follows. First, a 0.05 to 2.0% by weight aqueous solution of hyaluronic acid (salt) is prepared. Hyaluronic acid (salt) is hardly soluble in water, and easily becomes so-called mamako. Therefore, hyaluronic acid (salt) is gradually added to the water while stirring well to completely dissolve it. To the thus obtained aqueous solution of hyaluronic acid (salt) of 0.05 to 2.0% by weight, magnesium L-ascorbyl phosphate is added and thoroughly stirred to completely dissolve. Since the solubility of magnesium L-ascorbyl phosphate is 15 to 20%, the amount to be added is 0.05 to 0.05% as the amount of magnesium L-ascorbyl phosphate.
It is desirable to make it about 15.0% by weight. In this case, a concentrated aqueous solution of magnesium L-ascorbyl phosphate may be separately prepared and mixed with an aqueous solution of hyaluronic acid (salt). In the present invention, the ratio of hyaluronic acid (salt) to magnesium L-ascorbyl phosphate can be arbitrarily changed, but practically, 0.1 to 0.1 part by weight of hyaluronic acid (salt) is used in an amount of 0.1 to 10 parts by weight of hyaluronic acid (salt). 50 parts by weight is desirable.
水溶液の製造に用いる水としては特に制限されない
が、通常化粧品の製造に用いられるもの、例えばイオン
交換水、蒸留水が用いられる。また、該水溶液の製造に
用いる水として化粧水を用いることができる。The water used for the production of the aqueous solution is not particularly limited, but those usually used for the production of cosmetics, for example, ion-exchanged water and distilled water are used. In addition, lotion can be used as water used for producing the aqueous solution.
このようにして得られたヒアルロン酸(塩)とリン酸
−L−アスコルビルマグネシウムの混合水溶液を底が平
らで浅い容器に流し込む。粘稠なヒアルロン酸(塩)と
リン酸−L−アスコルビルマグネシウムの混合水溶液が
水平な表面を形成したところで、冷却し予備凍結せしめ
る。予備凍結の温度は−20〜−40℃が望ましい。これを
真空凍結乾燥機の中に入れ、高真空下で凍結乾燥する。
凍結乾燥の棚温度は常温から−20℃の範囲、真空度は1
トル(torr)以下が望ましい。凍結乾燥中に加温しても
良い。乾燥物を容器から取り出すと白色シート状(薄層
状)のヒアルロン酸(塩)とリン酸−L−アスコルビル
マグネシウムの混合体が得られる。予備凍結は真空凍結
乾燥機の中で行うことも出来る。この場合、予備凍結か
ら凍結乾燥までを真空凍結乾燥機の中で連続して操作す
ることが出来る。The mixed aqueous solution of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate thus obtained is poured into a shallow container having a flat bottom. When the mixed aqueous solution of viscous hyaluronic acid (salt) and magnesium L-ascorbyl phosphate forms a horizontal surface, it is cooled and pre-frozen. The pre-freezing temperature is desirably −20 to −40 ° C. This is placed in a vacuum freeze dryer and freeze dried under high vacuum.
Freeze drying shelf temperature ranges from room temperature to -20 ° C, vacuum degree is 1
Desirably less than torr. It may be heated during freeze-drying. When the dried product is taken out of the container, a white sheet (thin layer) mixture of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate is obtained. Pre-freezing can also be performed in a vacuum freeze dryer. In this case, the operation from pre-freezing to freeze-drying can be continuously performed in a vacuum freeze-dryer.
最近、化粧品は安全面での配慮から、製品の中の雑菌
の数を極力減らす方向にあるが、雑菌数の少ないシート
状ヒアルロン酸(塩)とリン酸−L−アスコルビルマグ
ネシウムの混合体を製造する場合は、ヒアルロン酸
(塩)とリン酸−L−アスコルビルマグネシウムの混合
水溶液を、0.5μm程度のフィルターを用いて、除菌濾
過する。除菌濾過した濾過液を清潔な真空凍結乾燥機の
中で凍結乾燥すると、雑菌数の少ないシート状ヒアルロ
ン酸(塩)とリン酸−L−アスコルビルマグネシウムの
混合体を得ることが出来る。Recently, cosmetics have been working to minimize the number of germs in products due to safety concerns, but have produced a mixture of hyaluronic acid (salt) in sheet form and magnesium L-ascorbyl phosphate with a low number of germs. In this case, a mixed aqueous solution of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate is sterilized and filtered using a filter of about 0.5 μm. By freeze-drying the filtrate after sterilization filtration in a clean vacuum freeze dryer, a mixture of sheet-shaped hyaluronic acid (salt) and magnesium L-ascorbyl phosphate having a small number of bacteria can be obtained.
ヒアルロン酸(塩)とリン酸−L−アスコルビンマグ
ネシウムの混合水溶液の濃度が薄い水溶液から作成した
凍結乾燥品は、非常に嵩密度の小さいシート状のものと
なるので物理的強度が非常に弱い。従って、実用的な物
理的強度を持つシートを得るには、0.1重量%程度以上
のヒアルロン酸(塩)とリン酸−L−アスコルビルマグ
ネシウムの混合水溶液を凍結乾燥することが望ましい。
ヒアルロン酸(塩)とリン酸−L−アスコルビルマグネ
シウムの混合体の濃度が濃い水溶液を凍結乾燥するとき
は、−40℃程度の温度で予備凍結を行った方が好ましい
結果が得られるが、予備凍結は必ずしも必要な操作では
ない。A freeze-dried product prepared from an aqueous solution having a low concentration of a mixed aqueous solution of hyaluronic acid (salt) and magnesium phosphate-L-ascorbic acid has a very low bulk density and thus a very low physical strength. Therefore, in order to obtain a sheet having practical physical strength, it is desirable to freeze-dry a mixed aqueous solution of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate of about 0.1% by weight or more.
When freeze-drying an aqueous solution having a high concentration of a mixture of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate, it is preferable to perform pre-freezing at a temperature of about -40 ° C. Freezing is not a necessary operation.
本発明の方法で得られるシート状ヒアルロン酸(塩)
とリン酸−L−アスコルビルマグネシウムの混合体の厚
さは混合水溶液の液層の深さを調節することにより、任
意の厚みを持ったものを製造することが出来る。実用的
には0.5〜3.0mm程度の厚みを持ったものが、化粧料とし
て使い易い。Sheet hyaluronic acid (salt) obtained by the method of the present invention
By adjusting the depth of the liquid layer of the mixed aqueous solution, a mixture having a desired thickness can be manufactured. Practically, those having a thickness of about 0.5 to 3.0 mm are easy to use as cosmetics.
ヒアルロン酸(塩)とリン酸−L−アスコルビンマグ
ネシウムの混合水溶液を底が平らで浅い容器に流し込む
場合、シリコン樹脂で表面処理した剥離紙を容器の底に
敷くと、シート状に乾燥した混合体を取り出す操作がス
ムースに行われる。When pouring a mixed aqueous solution of hyaluronic acid (salt) and magnesium phosphate-L-ascorbic acid into a shallow container having a flat bottom, a release paper treated with a silicone resin is spread on the bottom of the container, and the mixture is dried into a sheet. The operation of taking out is smoothly performed.
凍結乾燥は、0.05torr程度の高真空下で行う。 Lyophilization is performed under a high vacuum of about 0.05 torr.
本発明のシート状ヒアルロン酸(塩)とリン酸−L−
アスコルビルマグネシウムの混合体を作る際、混合水溶
液に、界面活性剤・増量剤・顔料・色素・キレート剤・
酸化防止剤・紫外線吸収剤・香料等を加えることが出来
る。Hyaluronic acid (salt) in sheet form of the present invention and phosphoric acid -L-
When making a mixture of ascorbyl magnesium, the mixed aqueous solution contains surfactants, extenders, pigments, dyes, chelating agents,
Antioxidants, ultraviolet absorbers, fragrances, etc. can be added.
本発明の方法で得られたシート状のヒアルロン酸
(塩)とリン酸−L−アスコルビルマグネシウムの混合
体は、水或いは化粧水に対して非常に溶けやすいという
特徴を持つ。予め、目尻等を化粧水で湿らせた部分に、
涙滴状、半月状、楕円形等適当な形と大きさに切断した
本発明のシート状化粧料を貼ると、シートは急速に溶解
して濃厚なヒアルロン酸(塩)とリン酸−L−アスコル
ビルマグネシウムの混合体の溶液となる。水或いは化粧
水が足りなくてシートが完全に溶解しない場合は、シー
トの上から水或いは化粧水を適量加えて滲み込ませて完
全に溶解させる。逆に涙滴状に切断した本発明のシート
状化粧料を目尻等の部分に貼り、その上を水或いは化粧
水で湿らせても良い。水或いは化粧水で湿ったシートを
指先で軽く押さえると、溶解は一層完全になる。一定時
間経過後、水で洗顔すると、容易にヒアルロン酸(塩)
とリン酸−L−アスコルビルマグネシウムの混合体は水
に溶け、皮膚から除くことが出来る。The mixture of sheet-shaped hyaluronic acid (salt) and magnesium L-ascorbyl phosphate obtained by the method of the present invention has a feature that it is very soluble in water or lotion. In the area where the corners of the eyes are moistened with lotion in advance,
When the sheet-shaped cosmetic of the present invention cut into an appropriate shape and size such as a teardrop, a half-moon, an oval or the like is applied, the sheet is rapidly dissolved and the concentrated hyaluronic acid (salt) and phosphoric acid-L- It becomes a solution of a mixture of ascorbyl magnesium. If the sheet does not completely dissolve due to lack of water or lotion, add an appropriate amount of water or lotion from the top of the sheet and allow it to completely dissolve. Conversely, the sheet-shaped cosmetic composition of the present invention cut into teardrops may be attached to a portion such as the outer corner of the eye, and the surface thereof may be moistened with water or lotion. Dissolving is more complete when the sheet moistened with water or lotion is gently pressed with a fingertip. After a certain period of time, if you wash your face with water, it will be easily hyaluronic acid (salt)
And magnesium phosphate-L-ascorbyl phosphate are soluble in water and can be removed from the skin.
本発明の方法で得られたシート状化粧料は、目尻以外
に瞼、額、口許、首等の小皺の出やすい部分に用いるこ
とが出来るが、これ以外の部分にも勿論用いることが出
来る。化粧料として用いた部分は、ヒアルロン酸(塩)
の持つ美容効果で皮膚に適度の「潤い」と「張り」が付
与されると共に、リン酸−L−アスコルビルマグネシウ
ムの美白効果で白くなる。The sheet-shaped cosmetic obtained by the method of the present invention can be used for parts other than the outer corner of the eye, such as the eyelids, forehead, mouth, and neck, where small wrinkles are likely to appear. Of course, it can be used for other parts. The part used as cosmetics is hyaluronic acid (salt)
With the beauty effect of the present invention, appropriate "moisturizing" and "tension" are imparted to the skin, and the skin is whitened by the whitening effect of magnesium phosphate-L-ascorbyl.
(発明の効果) 本発明により、水或いは化粧水に対して非常に溶解性
の良いシート状のヒアルロン酸(塩)とリン酸−L−ア
スコルビルマグネシウムの混合体からなる化粧料を製造
することが出来、これを用いてヒアルロン酸(塩)とリ
ン酸−L−アスコルビルマグネシウムの混合体を主剤と
した荒肌改善効果、角質改善効果、角質層のターンオー
バーを速くする効果、美肌効果等の皮膚老化防止効果等
に優れたワンポイント化粧料を製造することが出来る。(Effects of the Invention) According to the present invention, it is possible to produce a cosmetic comprising a mixture of hyaluronic acid (salt) and magnesium L-ascorbyl phosphate in a sheet form having excellent solubility in water or lotion. It can be used to improve skin roughness, keratin, turnover of stratum corneum quickly, and skin effect, etc., based on a mixture of hyaluronic acid (salt) and magnesium phosphate-L-ascorbyl. It is possible to produce a one-point cosmetic having an excellent anti-aging effect.
(実施例) 実施例1 ヒアルロン酸(分子量:120万)0.50gを、純水100ml中
に溶解させた。この溶液に1.0gのリン酸−L−アスコル
ビルマグネシウムを加え、よく撹拌しつつ完全に溶解さ
せた。この混合溶液を0.45μmのフィルターで濾過し
た。濾液をアルミ製のバットに厚さ2mmになるように入
れ、−40℃に冷却した凍結乾燥機(ラブコンコ社製、ス
トッパリングトレイドライヤー)で予備凍結した。予備
凍結終了後、20時間、真空度:0.05torrで凍結乾燥し、
シート状ヒアルロン酸とリン酸−L−アスコルビルマグ
ネシウムの混合体1.32gを得た。これを縦3cm、横4cmの
長方形に切断し、一辺32mgのシート状化粧品とした。(Example) Example 1 0.50 g of hyaluronic acid (molecular weight: 1.2 million) was dissolved in 100 ml of pure water. To this solution, 1.0 g of magnesium L-ascorbyl phosphate was added and completely dissolved with good stirring. This mixed solution was filtered with a 0.45 μm filter. The filtrate was put into an aluminum vat so as to have a thickness of 2 mm, and preliminarily frozen by a freeze dryer (manufactured by Labconco, stopper ring tray dryer) cooled to -40 ° C. After pre-freezing, freeze-dried for 20 hours at a vacuum of 0.05 torr,
1.32 g of a mixture of sheet hyaluronic acid and magnesium L-ascorbyl phosphate was obtained. This was cut into a rectangle having a length of 3 cm and a width of 4 cm to obtain a sheet-shaped cosmetic having a side of 32 mg.
このシート状化粧品を、薄く水を張ったシャーレに入
れたところ、水を吸収して極短時間のうちに溶解した。When this sheet-shaped cosmetic was put into a petri dish filled with water, it absorbed water and dissolved within a very short time.
比較例1 ヒアルロン酸(分子量:120万)0.50gを、純水100ml中
に溶解させた。この溶液に1.0gのリン酸−L−アスコル
ビルマグネシウムを加え、よく撹拌しつつ完全に溶解さ
せた。この混合溶液を0.45μmのフィルターで濾過し
た。濾液をアルミ製のバットに厚さ2mmになるように入
れ、恒温乾燥機中で温度60℃で16時間乾燥した。フィル
ム状のヒアルロン酸とリン酸−L−アスコルビルマグネ
シウムの混合体1.40gを得た。これを縦3cm、横4cmの長
方形に切断した。Comparative Example 1 0.50 g of hyaluronic acid (molecular weight: 1.2 million) was dissolved in 100 ml of pure water. To this solution, 1.0 g of magnesium L-ascorbyl phosphate was added and completely dissolved with good stirring. This mixed solution was filtered with a 0.45 μm filter. The filtrate was put into an aluminum vat so as to have a thickness of 2 mm, and dried in a thermostatic dryer at a temperature of 60 ° C. for 16 hours. 1.40 g of a mixture of hyaluronic acid and magnesium L-ascorbyl phosphate in the form of a film was obtained. This was cut into a rectangle 3 cm long and 4 cm wide.
このフィルムを、薄く水を貼ったシャーレに入れたと
ころ、10分経っても、膨潤はしたが溶解しなかった。When this film was placed in a petri dish with water, it swelled but did not dissolve even after 10 minutes.
実施例2 醗酵法で製造したヒアルロン酸ナトリウム(分子量:1
20万)10gを精製水5中に溶解させた。このヒアルロ
ン酸ナトリウム溶液にリン酸−L−アスコルビンマグネ
シウム190gを添加し、撹拌して完全に溶解せしめた。こ
の混合溶液を、0.45μmのフィルターで濾過した。濾液
をアルミ製のバットに厚さ2mmになるように入れ、−50
℃に冷却した凍結乾燥機(共和社製、真空凍結乾燥機RL
−2412BS)内で予備凍結した。予備凍結終了後、2日
間、真空度:0.05torrで凍結乾燥し、シート状ヒアルロ
ン酸ナトリウムとリン酸−L−アスコルビンマグネシウ
ムの混合体180gを得た。これを縦3cm、横4cmの長方形に
切断し、シート状化粧品とした。Example 2 Sodium hyaluronate produced by a fermentation method (molecular weight: 1
200,000) was dissolved in purified water 5. To this sodium hyaluronate solution was added 190 g of magnesium L-ascorbyl phosphate, and the mixture was stirred and completely dissolved. This mixed solution was filtered with a 0.45 μm filter. Pour the filtrate into an aluminum vat to a thickness of 2 mm, and
Freeze dryer (Kyowa Co., Ltd., vacuum freeze dryer RL)
-2412BS). After the preliminary freezing was completed, the mixture was freeze-dried for 2 days at a degree of vacuum of 0.05 torr to obtain 180 g of a sheet-like mixture of sodium hyaluronate and magnesium L-ascorbin phosphate. This was cut into a rectangle having a length of 3 cm and a width of 4 cm to obtain a sheet-shaped cosmetic.
このシート状化粧品を、薄く水を張ったシャーレに入
れたところ、水を吸収して極単時間のうちに溶解した。When this sheet-like cosmetic was put in a petri dish filled with water, it absorbed water and dissolved within a very short time.
比較例2 実施例2で使用したものと同様のヒアルロン酸ナトリ
ウムとリン酸−L−アスコルビルマグネシウムの混合溶
液の濾液をアルミ製のバットに厚さ2mmになるように入
れ、恒温乾燥機中で温度60℃で8時間乾燥した。フィル
ム状のヒアルロン酸ナトリウムとリン酸−L−アスコル
ビルマグネシウムの混合体5.4kgを得た。これを縦3cm、
横4cmの長方形に切断した。Comparative Example 2 A filtrate of a mixed solution of sodium hyaluronate and magnesium L-ascorbyl phosphate similar to that used in Example 2 was placed in an aluminum vat so as to have a thickness of 2 mm, and heated in a thermostatic drier. Dry at 60 ° C. for 8 hours. 5.4 kg of a film-like mixture of sodium hyaluronate and magnesium L-ascorbyl phosphate was obtained. This is 3cm long,
It was cut into rectangles 4 cm wide.
このフィルムを、薄く水を張ったシャーレに入れたと
ころ、10分経っても完全には溶解しなかった。When this film was placed in a petri dish filled with water, it was not completely dissolved even after 10 minutes.
実施例3 本発明のシート状ヒアルロン酸ナトリウムとリン酸−
L−アスコルビルマグネシウムの混合体からなる化粧料
の作用効果について、使用テストによって試験を行っ
た。使用テストは10名の色黒の女性をパネラーとした。
実施例2の条件で得られたヒアルロン酸ナトリウムとリ
ン酸−L−アスコルビルマグネシウムの混合体からなる
シート状の化粧料は目、鼻、口の部分をくり抜きマスク
状に成型した。Example 3 Sheet-shaped sodium hyaluronate of the present invention and phosphoric acid-
The effect of the cosmetic comprising the mixture of L-ascorbyl magnesium was tested by a use test. The usage test was conducted with 10 black and white women as panelists.
The sheet-like cosmetic comprising the mixture of sodium hyaluronate and magnesium L-ascorbyl phosphate obtained under the conditions of Example 2 was molded into a mask shape by hollowing out the eyes, nose and mouth.
テストは、毎日夜、洗顔後、第1表に示す組成の化粧
水を適量、顔の部分に塗布し、その上に上記の成型した
シート状化粧料を貼りつけた。化粧水が足りなくてシー
トが完全に溶解出来ないときは、シートの上から化粧水
を適量浸み込まさせ、指先でかるく押さえて完全に溶解
させた。1夜、その状態に保ち、翌朝水で洗顔し、化粧
料を洗い落とした。In the test, after washing the face every night, an appropriate amount of lotion having the composition shown in Table 1 was applied to the face, and the above-mentioned molded sheet-like cosmetic was stuck thereon. When the lotion was insufficient and the sheet could not be completely dissolved, an appropriate amount of lotion was soaked from above the sheet and pressed completely with a fingertip to completely dissolve. One night, it was kept in that state, and the next morning, the face was washed with water, and the cosmetics were washed off.
テストは2ヶ月にわたって行い、評価は第2表記載の
3項目についてパネラー本人が、その有効性を判定し
た。結果は第2表に示す通りである。The test was conducted over two months, and the panelists themselves evaluated the effectiveness of the three items listed in Table 2 for their effectiveness. The results are as shown in Table 2.
第1表 化粧水の組成 (重量%) エタノール 8.0% プロピレングリコール 4.0% グリセリン 3.0% ポリオキシエチレンオレイル アルコールエーテル 1.0% クエン酸ソーダ 0.1% p−オキシ安息香酸メチルエステル 0.1% イオン交換水 残量 第2表の結果から明らかなように、本発明のヒアルロ
ン酸ナトリウムとリン酸−L−アスコルビンマグネシウ
ムの混合体からなるシート状の化粧料は肌の潤い、肌の
張り、美白効果が認められた。Table 1 Composition of lotion (wt%) Ethanol 8.0% Propylene glycol 4.0% Glycerin 3.0% Polyoxyethylene oleyl alcohol ether 1.0% Sodium citrate 0.1% Methyl p-oxybenzoate 0.1% Ion-exchanged water As is clear from the results in Table 2, the sheet-like cosmetic comprising the mixture of sodium hyaluronate and magnesium phosphate-L-ascorbic acid of the present invention was found to have moisturizing, firming and whitening effects on the skin. .
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭58−216109(JP,A) 特開 昭61−37710(JP,A) 特開 昭60−116618(JP,A) 特開 昭62−129212(JP,A) (58)調査した分野(Int.Cl.6,DB名) A61K 7/00 - 7/50 ──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-58-216109 (JP, A) JP-A-61-37710 (JP, A) JP-A-60-116618 (JP, A) JP-A-62 129212 (JP, A) (58) Fields investigated (Int. Cl. 6 , DB name) A61K 7/00-7/50
Claims (3)
アスコルビルマグネシウムとからなる水溶液を薄層状に
真空凍結乾燥することを特徴とする水易溶解性のシート
状化粧料の製造法。(1) hyaluronic acid or a salt thereof and phosphoric acid-L-
A method for producing a water-soluble sheet-like cosmetic, comprising vacuum-drying an aqueous solution comprising ascorbyl magnesium in a thin layer.
て、リン酸−L−アスコルビルマグネシウムを0.1〜50
重量部の割合で両者を水に溶解した水溶液を薄層状に真
空凍結乾燥することを特徴とする請求項1記載の製造
法。2. An amount of magnesium L-ascorbyl phosphate 0.1 to 50 parts by weight per 1 part by weight of hyaluronic acid or a salt thereof.
2. The method according to claim 1, wherein an aqueous solution in which both are dissolved in water at a ratio of parts by weight is freeze-dried in a thin layer.
製造法。3. The method according to claim 1, wherein the water is a lotion.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24795789A JP2887681B2 (en) | 1989-09-26 | 1989-09-26 | Manufacturing method of sheet cosmetics |
| FR9009654A FR2650180B1 (en) | 1989-07-31 | 1990-07-27 | PROCESS FOR PRODUCING AN EASILY WATER-SOLUBLE SHEET BASED ON HYALURONIC ACID OR HYALURONATE AND SHEET THUS OBTAINED |
| DE19904024180 DE4024180A1 (en) | 1989-07-31 | 1990-07-30 | BLAETTER, COMPREHENSIVE HYALURONIC ACID, THEIR MANUFACTURE AND METHOD FOR THEIR USE |
| GB9016817A GB2235204B (en) | 1989-07-31 | 1990-07-31 | Preparation of easily water-soluble sheets comprising hyaluronic acid or hyaluronate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24795789A JP2887681B2 (en) | 1989-09-26 | 1989-09-26 | Manufacturing method of sheet cosmetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP27695998A Division JPH11152204A (en) | 1988-12-28 | 1998-09-30 | Sheet cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03112914A JPH03112914A (en) | 1991-05-14 |
| JP2887681B2 true JP2887681B2 (en) | 1999-04-26 |
Family
ID=17171070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24795789A Expired - Fee Related JP2887681B2 (en) | 1989-07-31 | 1989-09-26 | Manufacturing method of sheet cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2887681B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002284623A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | Cosmetics |
| JP2010043022A (en) * | 2008-08-12 | 2010-02-25 | Kao Corp | Sheet-shaped cosmetic product |
| JP2010163386A (en) * | 2009-01-15 | 2010-07-29 | Chisso Corp | Cosmetic sheet |
| JP2013112625A (en) * | 2011-11-25 | 2013-06-10 | Keiwa Inc | Cosmetic sheet for skin and method for producing cosmetic sheet for skin |
-
1989
- 1989-09-26 JP JP24795789A patent/JP2887681B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03112914A (en) | 1991-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2650180A1 (en) | PROCESS FOR PRODUCING AN EASILY WATER SOLUBLE SHEET BASED ON HYALURONIC ACID OR HYALURONATE AND SHEET THUS OBTAINED | |
| KR100955846B1 (en) | Cosmetic composition having skin astringent effect | |
| CN105963153A (en) | Active composition containing copper peptide and cosmetic or skin care product | |
| CN108478459A (en) | Eye essence containing lactobacillus fermentation lysate and preparation method thereof | |
| JP2023502305A (en) | Nanofiber Matrix Made of Natural Polymers with Natural Functional Ingredients for Cosmetics | |
| CN102920631A (en) | Elastic fibers forming accelerant | |
| JP2001261570A (en) | External preparation for skin | |
| KR102758052B1 (en) | Microcapsule based on chitosan containing for sustained release and enhanced absorption of low molecular collagen and method for preparing the same | |
| JP3987793B2 (en) | Topical skin preparation | |
| JP2002212087A (en) | External preparation for skin | |
| CN1985791B (en) | Preparation method of skin care silk fibroin gel cream | |
| JPH0363209A (en) | Production of sheet-like hyaluronic acid or its salt and its use | |
| CN103479567A (en) | Epidermal growth factor complex lipidosome, and preparation method and application of lipidosome | |
| JPH11152204A (en) | Sheet cosmetic | |
| CN109125211A (en) | A kind of anti-ageing activating essence of whitening and preparation method thereof | |
| JP2887681B2 (en) | Manufacturing method of sheet cosmetics | |
| JP3449624B2 (en) | Method for producing cosmetics and swallow fossil extract | |
| KR20210141142A (en) | Cosmetic compositions for skin care and hair care and preparation methods thereof | |
| JP4871438B2 (en) | Cosmetics | |
| JPH09301819A (en) | Cosmetic containing enka-extract | |
| JP2025019175A (en) | Collagen hydrogel film forming agent | |
| JP2012201615A (en) | Elastase activity inhibitor | |
| JP2011195539A (en) | Elastase activity inhibitor | |
| JP3044690B2 (en) | Cosmetics | |
| CN115364014A (en) | Multi-effect moisturizing factor and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |